Strength at Home Program for Domestic Violence
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Strength at Home treatment for domestic violence?
Research shows that the Strength at Home (SAH) program, a therapy designed to address intimate partner violence (IPV), has been effective in reducing IPV among military veterans and civilians. Participants in the program reported significant decreases in IPV and related issues like PTSD symptoms and alcohol use, with these improvements lasting for at least six months after treatment.12345
How does the Strength at Home treatment for domestic violence differ from other treatments?
The Strength at Home (SAH) program is unique because it is a trauma-informed, cognitive-behavioral group treatment specifically designed for military and veteran populations to address intimate partner violence (IPV). It focuses on reducing IPV by considering the unique experiences of veterans and service members, which is not commonly addressed in other IPV treatments.12678
What is the purpose of this trial?
The goal of this study is to conduct a randomized controlled trial (RCT) comparing outcomes between two programs to reduce intimate partner violence (IPV)- the Strength at Home (SAH) program and a standard, state-approved IPV intervention program, Treatment as Usual (TAU). Primary outcomes will include self- and partner-reported physical and psychological IPV. Secondary outcomes will include self-reported PTSD symptoms, alexithymia, alcohol use problems, and treatment satisfaction, assessed across five time points.
Research Team
Casey T Taft, PhD
Principal Investigator
CABU School Medicine, Psychiatry
Lindsay Orchowski, PhD
Principal Investigator
Rhode Island Hospital
Eligibility Criteria
This trial is for men mandated by the Rhode Island court to undergo intervention for intimate partner violence (IPV) and their partners. There are no specific exclusion criteria mentioned, so it appears open to all individuals who meet the inclusion terms.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either the Strength at Home (SAH) program for 12 weeks or the Treatment as Usual (TAU) program for 20 weeks
Follow-up
Participants are monitored for outcomes such as IPV, PTSD symptoms, and treatment satisfaction every three months post-treatment through month 12
Treatment Details
Interventions
- SAH
- TAU
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University
Lead Sponsor
Rhode Island Hospital
Collaborator
Patient-Centered Outcomes Research Institute
Collaborator